543 related articles for article (PubMed ID: 19766350)
1. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study).
El-Mofty M; El Weshahy H; Youssef R; Abdel-Halim M; Mashaly H; El Hawary M
Photodermatol Photoimmunol Photomed; 2008 Feb; 24(1):38-42. PubMed ID: 18201356
[TBL] [Abstract][Full Text] [Related]
5. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
Inzinger M; Heschl B; Weger W; Hofer A; Legat FJ; Gruber-Wackernagel A; Tilz H; Salmhofer W; Quehenberger F; Wolf P
Br J Dermatol; 2011 Sep; 165(3):640-5. PubMed ID: 21564068
[TBL] [Abstract][Full Text] [Related]
7. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.
Torras H; Aliaga A; López-Estebaranz JL; Hernández I; Gardeazabal J; Quintanilla E; Mascaró JM
J Dermatolog Treat; 2004 Apr; 15(2):98-103. PubMed ID: 15204160
[TBL] [Abstract][Full Text] [Related]
8. Narrowband ultraviolet B versus psoralen plus ultraviolet A therapy for severe plaque psoriasis: an Indian perspective.
Chauhan PS; Kaur I; Dogra S; De D; Kanwar AJ
Clin Exp Dermatol; 2011 Mar; 36(2):169-73. PubMed ID: 20545955
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin for the treatment of plaque-type psoriasis.
Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
11. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
[TBL] [Abstract][Full Text] [Related]
12. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
[TBL] [Abstract][Full Text] [Related]
13. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy.
Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS
Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.
Berneburg M; Herzinger T; Rampf J; Hoetzenecker W; Guenova E; Meisner C; Maetzke J; Schaefer T; Eberlein B; Scharffetter-Kochanek K; Rocken M
Br J Dermatol; 2013 Sep; 169(3):704-8. PubMed ID: 23772997
[TBL] [Abstract][Full Text] [Related]
16. Twice- vs. thrice-weekly MPD PUVA in psoriasis: a randomized-controlled efficacy study.
Valbuena MC; Hernández O; Rey M; Sánchez G; de Quintana LP
Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):126-9. PubMed ID: 17598865
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial.
Mittal R; Malhotra S; Pandhi P; Kaur I; Dogra S
Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660
[TBL] [Abstract][Full Text] [Related]
19. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
Papp KA; Tyring S; Lahfa M; Prinz J; Griffiths CE; Nakanishi AM; Zitnik R; van de Kerkhof PC; Melvin L;
Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
